Vetoquinol (France) Performance
| VETO Stock | EUR 77.80 0.40 0.51% |
The entity has a beta of -0.2, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Vetoquinol are expected to decrease at a much lower rate. During the bear market, Vetoquinol is likely to outperform the market. At this point, Vetoquinol has a negative expected return of -0.26%. Please make sure to validate Vetoquinol's kurtosis, daily balance of power, and the relationship between the skewness and accumulation distribution , to decide if Vetoquinol performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Vetoquinol has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 129.3 M | |
| Total Cashflows From Investing Activities | -33.4 M |
Vetoquinol |
Vetoquinol Relative Risk vs. Return Landscape
If you would invest 9,300 in Vetoquinol on September 3, 2024 and sell it today you would lose (1,520) from holding Vetoquinol or give up 16.34% of portfolio value over 90 days. Vetoquinol is generating negative expected returns and assumes 1.731% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Vetoquinol, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Vetoquinol Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vetoquinol's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vetoquinol, and traders can use it to determine the average amount a Vetoquinol's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1497
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VETO |
Estimated Market Risk
| 1.73 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vetoquinol is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vetoquinol by adding Vetoquinol to a well-diversified portfolio.
Vetoquinol Fundamentals Growth
Vetoquinol Stock prices reflect investors' perceptions of the future prospects and financial health of Vetoquinol, and Vetoquinol fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vetoquinol Stock performance.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0774 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 938.81 M | |||
| Shares Outstanding | 11.88 M | |||
| Price To Earning | 20.18 X | |||
| Price To Book | 2.25 X | |||
| Price To Sales | 1.94 X | |||
| Revenue | 521.27 M | |||
| EBITDA | 118.86 M | |||
| Cash And Equivalents | 117.63 M | |||
| Cash Per Share | 9.93 X | |||
| Total Debt | 7.07 M | |||
| Debt To Equity | 1.80 % | |||
| Book Value Per Share | 39.25 X | |||
| Cash Flow From Operations | 89.72 M | |||
| Earnings Per Share | 5.31 X | |||
| Total Asset | 624.56 M | |||
| Retained Earnings | 14 M | |||
| Current Asset | 227 M | |||
| Current Liabilities | 75 M | |||
About Vetoquinol Performance
By analyzing Vetoquinol's fundamental ratios, stakeholders can gain valuable insights into Vetoquinol's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Vetoquinol has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vetoquinol has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. Vetoquinol SA was founded in 1933 and is headquartered in Lure, France. Vetoquinol operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 2004 people.Things to note about Vetoquinol performance evaluation
Checking the ongoing alerts about Vetoquinol for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vetoquinol help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vetoquinol generated a negative expected return over the last 90 days | |
| About 67.0% of the company outstanding shares are owned by insiders |
- Analyzing Vetoquinol's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vetoquinol's stock is overvalued or undervalued compared to its peers.
- Examining Vetoquinol's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vetoquinol's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vetoquinol's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vetoquinol's stock. These opinions can provide insight into Vetoquinol's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Vetoquinol Stock analysis
When running Vetoquinol's price analysis, check to measure Vetoquinol's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vetoquinol is operating at the current time. Most of Vetoquinol's value examination focuses on studying past and present price action to predict the probability of Vetoquinol's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vetoquinol's price. Additionally, you may evaluate how the addition of Vetoquinol to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |